Safety and efficacy of piribedil as adjunctive treatment for Parkinson's disease: Six-month placebo-controlled study | Charles Explorer

Safety and efficacy of piribedil as adjunctive treatment for Parkinson's disease: Six-month placebo-controlled study

Publikace

Abstrakt

Piribedil, Parkinson's disease

Osoby